You are here:
Home
NICE Guidance
NICE Advice
Evidence summaries
Chronic obstructive pulmonary disease: fluticasone furoate, umeclidinium and vilanterol (Trelegy)
Evidence summary
Reference number:
ES18
Published:
14 June 2018
Last updated:
15 December 2021
This evidence summary has been updated and replaced by
NICE guideline 115
.
Back to top